EXPERIENCE

Jeffrey regularly advises major pharmaceutical companies in connection with licensing and collaboration agreements and manufacturing and supply arrangements. He has significant experience in numerous transactions involving novel therapeutic modalities, including genetic medicine and AI-assisted target and drug discovery.

Jeffrey also regularly leads the technology and intellectual property aspects of major corporate transactions, including commercial arrangements associated with such transactions; and advises on the treatment of intellectual property matters in bankruptcy cases.

AWARDS & RECOGNITIONS

Ranked Band 1 by Chambers in the Technology category, Jeffrey is described by clients as “by far the premier licensing and collaboration attorney in the country" and “a fierce advocate for his clients, equipped with an arsenal of industry-specific knowledge." Jeffrey is recognized by the Legal 500 as a “Leading Lawyer” in the Media, Technology and Telecoms: Technology Transactions category and is recommended in the Patents: Licensing, Technology Transactions, Media and Entertainment: Transactional and Healthcare: Life Sciences categories.

Jeffrey is also recognized as a “Global Leader” in New York by IAM Global Leaders and is “Highly Recommended” by IAM Patent 1000, where clients have noted he has “a stellar ability to see the forest through the trees, is a clear and concise draftsman and a constructive negotiator,” and he is “the kind of sophisticated IP lawyer you need on a tough deal – he understands his clients’ industry and business, and fights hard while communicating clearly in negotiations to get to a resolution.”

Jeffrey was named an “IP Star” in the IP Transactions and Trademarks category by Managing Intellectual Property and a “Life Sciences Star” by LMG Life Sciences Guide. He has received numerous recognitions from Best Lawyers in America including “Best Lawyer” for Information Technology Law and Technology Law in New York in 2024 and “Lawyer of the Year” for Technology Law in 2024, 2022 and 2020. Jeffrey was shortlisted for “Practitioner of the Year” for IP Transactions by Managing Intellectual Property’s Americas Awards in 2022. Jeffrey was featured as one of the “500 Leading Dealmakers in America” by Lawdragon in 2025, and has been recognized as a Law360 MVP in the Technology category.